Aromando Andrew insider trades
Aromando Andrew has filed 6 Form 4s with the SEC that we hold, for AMAM (Chief Operating Officer), AMAM (Chief Operating Officer) and Oncolytics Biotech INC (ONCY) (Chief Business Officer). Across all of them we count 1 purchase worth $25.5K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($25.5K) and 0 sales ($0). The largest single trade was a purchase of 29,600 shares of Oncolytics Biotech INC worth $25.5K, dated 2026-02-11. The first filing on our record is dated 2023-05-05 and the latest 2026-06-03.
AMAM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
AMAM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Oncolytics Biotech INC (ONCY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-11 | P, purchase reported on Form 4 | 29,600 | $25.5K | 2026-02-13 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1976455) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms